1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Africa Malaria Treatment Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. High prevalence of malaria
3.2.1.2. Malaria elimination programs
3.2.1.3. Rising research and development activities
3.2.1.4. Improved patient compliance
3.2.2. Restraints
3.2.2.1. Drug resistance
3.2.2.2. Limited access to healthcare
3.2.3. Opportunities
3.2.3.1. Focus on affordable and accessible treatments
3.2.3.2. Advancement in diagnostic tools
3.2.4. Challenges
3.2.4.1. Lack of awareness and behavior change
3.2.4.2. Environmental and climate change
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Africa Malaria Treatment Market: Marketing Strategies
5. Africa Malaria Treatment Market Overview
5.1. Market Size & Forecast, 2019-2030
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Treatment
5.2.1.1. Prescription Medications
5.2.1.2. Vaccines
5.2.1.3. Diagnostic Tests
5.2.1.4. Others
5.2.2. By Drug Type
5.2.2.1. Branded
5.2.2.2. Generic
5.2.3. By Route of Administration
5.2.3.1. Oral and Parental
5.2.3.2. Intravenous
5.2.4. By Distribution Channel
5.2.4.1. Direct Tender
5.2.4.2. Hospital Pharmacies
5.2.4.3. Retail Pharmacies
5.2.4.4. Online Pharmacies
5.2.4.5. Others
5.2.5. By End User
5.2.5.1. Hospitals
5.2.5.2. Specialty Clinics
5.2.5.3. Home care
5.2.5.4. Others
5.2.6. By Country
5.2.6.1. South Africa
5.2.6.2. Nigeria
5.2.6.3. Algeria
5.2.6.4. Rest of Africa
6. South Africa Malaria Treatment Market
6.1. Market Size & Forecast, 2019-2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Treatment
6.2.2. By Drug Type
6.2.3. By Route of Administration
6.2.4. By Distribution Channel
6.2.5. By End User
7. Nigeria Malaria Treatment Market
7.1. Market Size & Forecast, 2019-2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Treatment
7.2.2. By Drug Type
7.2.3. By Route of Administration
7.2.4. By Distribution Channel
7.2.5. By End User
8. Algeria Malaria Treatment Market
8.1. Market Size & Forecast, 2019-2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Treatment
8.2.2. By Drug Type
8.2.3. By Route of Administration
8.2.4. By Distribution Channel
8.2.5. By End User
9. Rest of Africa Malaria Treatment Market
9.1. Market Size & Forecast, 2019-2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Treatment
9.2.2. By Drug Type
9.2.3. By Route of Administration
9.2.4. By Distribution Channel
9.2.5. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Africa Malaria Treatment Company Market Share Analysis, 2023
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Escalating Geopolitical Tension on Africa Malaria Treatment Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Cipla Ltd
12.2. Sun Pharmaceutical Industries Ltd
12.3. Sanofi SA
12.4. GSK Plc
12.5. Novartis
12.6. Hikma Pharmaceuticals PLC
12.7. Sun Pharmaceutical Industries Ltd.
12.8. Zydus Cadila
12.9. Bliss GVS Pharma Ltd.
12.10. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.